Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Soterius, Inc. logo — Technology Enabled Drug Safety, Medical Affairs and Regulato...

Soterius, Inc.

Technology Enabled Drug Safety, Medical Affairs and Regulatory Services

Founded 2007 United States Princeton, United States 121 employees Series A Biotechnology, Health Care +1

General Information

Company Name Soterius, Inc.
Founded Year 2007
Location United States Princeton, United States
Employees 121
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Service Fee, Usage Based, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Soterius, Inc.. To contact Soterius, Inc., visit soterius.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Soterius, Inc. compare?

A PDF of Soterius, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Soterius, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Soterius, Inc.

Soterius, Inc., established in 2007, is a dynamic player in the Biotechnology, Health Care, and Pharmaceutical industries. The United States-based company is spearheading innovation with its slogan: "Technology Enabled Drug Safety, Medical Affairs and Regulatory Services."

Soterius has garnered attention for its ability to design customized, innovative, and cost-effective processes in clinical safety, pharmacovigilance, and medical affairs. Leveraging deep industry knowledge, Soterius combines agile, human intelligence with big data to deliver pioneering, customer-centric solutions.

The company, headquartered in the United States, received a Series A investment on December 18, 2019, with Celegence as a key investor. This financial backing underscores confidence in Soterius' strategic vision and operational capabilities. As Soterius continues to integrate cutting-edge technology and life science expertise, it remains a notable entity for investors seeking opportunities in health innovation.

Business keywords: Clinical Safety, Pharmacovigilance, Medical Affairs, Regulatory Services, Signal Detection, Safety Data Exchange Agreements, Aggregate Reports, Outcomes Research, Safety Database, EU QPPV, Medical Writing Services, Drug Development Support, Technology-Enabled Services

Services & Products

Clinical SAE Processing & Expedited Reporting
Medical Review of SAE
Pharmacovigilance SOPs and Safety System Setup
Postmarketed Pharmacovigilance Services
Aggregate Reports Submission
Managed Services for Drug Safety
Signal Management
Development Safety Update Report Authoring

Target Customers

Pharmaceutical Companies Biotech Firms Healthcare Organizations Regulatory Bodies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Celegence
18 Dec 2019

Soterius, Inc. Alternatives & Competitors

View All Alternatives
Soterius, Inc. vs
Medpace
Medpace United States

Accelerating Drug, Biologic and Medical Device Clinical Development

5796 employees
Biotechnology, Pharmaceutical
Soterius, Inc. vs
APCER Life Sciences
APCER Life Sciences United Kingdom

Together for better health

990 employees
Biopharma, Biotechnology
Soterius, Inc. vs
ArisGlobal
ArisGlobal United States

Innovative Cloud Solutions for Drug Safety, Data & Analytics, Regulatory and Medical Affairs.

Private Equity
1977 employees
AI, Biotechnology
Also compare with: Soterius, Inc. vs G2 BioPharma Services Inc. G2 BioPharma Services Inc. View all alternatives

FAQ About Soterius, Inc.

Technology Enabled Drug Safety, Medical Affairs and Regulatory Services
Soterius, Inc. was founded in 2007.
Soterius, Inc. is headquartered in Princeton, United States.
Soterius, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Clinical Safety, Pharmacovigilance, Medical Affairs and Regulatory Services. Its customers include Pharmaceutical Companies, Biotech Firms and Healthcare Organizations.
Soterius, Inc. has a B2B, SaaS and Platform business model. Its revenue comes from Service Fee, Usage Based and Consulting Fee.
Soterius, Inc. has approximately 121 employees.
Soterius, Inc. has completed 1 funding round. The latest funding stage is Series A.
Soterius, Inc. offers: Clinical SAE Processing & Expedited Reporting, Medical Review of SAE, Pharmacovigilance SOPs and Safety System Setup, Postmarketed Pharmacovigilance Services, Aggregate Reports Submission, Managed Services for Drug Safety, Signal Management, Development Safety Update Report Authoring, Collaborative Medical Writing with Generative AI.
Top alternatives and competitors to Soterius, Inc. include Medpace, APCER Life Sciences, ArisGlobal, Drug Safety Navigator (DSN), HiRO - Harvest Integrated Research Organization. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Soterius, Inc. and Medpace are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Soterius, Inc., https://bouncewatch.com/company/soterius-inc, updated 27 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes